If you or a loved one is living with relapsed or refractory multiple myeloma, exploring a clinical trial may be an option worth considering. A clinical study is now enrolling across the U.S. and is evaluating a potential treatment designed to help the immune system better recognize and target myeloma cells. For some patients, clinical trials can offer an important opportunity to learn about new treatment approaches. HealthTree is here to help you understand whether this study may be a good fit and to support you every step of the way. 🔎 Explore your options 🤝 Get personalized guidance 📍 Multiple study locations nationwide Want more information? Email us at support@healthtree.org https://clinicaltrials.gov/study/NCT06158841